2Kim DY, Kim HR, Shim JH, et al. Significance of serum and tissue carcinoembryonic antigen for the prognosis of gastric carcinoma patients [J]. J Surg Oncol, 2000,74 (3): 185-192.
3Duraker N, Celik AN. The prognostic significance of preoperative serum CA19-9 in patients with respectable gastric carcinoma: comparison with CEA[J]. J Surg Oncol, 2001,76(4):266-271.
4Marrelli D, Pinto E, De Stefano A, et al. Preoperative positivity of serum tumor markers in a strong predictor of hematogenous recurrence of gastric cancer [J]. J Surg Oncol, 2001,78(4):253-258.
5Bando E, Yonemura Y, Tabesbita Y, et al. Intraoperative lavage for cytological examination in 1 297 patients with gastric carcinoma [J]. Am J Surg, 1999,178(3) :256--262.
6Nakata B, Hirakawa YS, Chung K, et al. Serum CA125 level as a predictor of peritoneal dissemination in patients with gastric carcinoma [J]. Cancer, 1998,83(12):2488-2492.
7Pectasides D, Mylonalakis A, Kostopoulou M, et al.CEA, CA19-9, and CA-50 in monitoring gastric carcinoma [J]. Am J Clin Oncol, 1997,20(4): 348-353.
8Nakata B, Chung K, Muguruma K, et al. Changes in tumor marker levels as a predictor of chemotherapeutic effect in patients with gastric carcinoma [J].Cancer, 1998,83(1) : 19-24.
9Gaspar MJ Arribas I, Coca MC, et al. Prognostic value of carcinoembryonic antigen, CA19-9 and CA72-4 in gastric carcinoma [J]. Tumor Biol, 2001,22(5):318--322.
10Choi JH, Oh JY, Ryu SK, et al. Detection of epidermal growth factor receptor in the serum of gastric carcinoma patients [J]. Cancer, 1997,79(10) : 1879-1883.
